A randomized trial of adjuvant chemotherapy with FEC 50 vs. FEC 100 for nodepositive operable breast cancer early report. - Bonneterre,J..; Roché,H..; Bremond,A..; Kerbrat,P..; Namer,M..; Fumoleau,P.. (Proc ASCO, 1996)